Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients. (September 2021)

Record Type:: Journal Article
Title:: Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients. (September 2021)
Main Title:: Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients
Authors:: Morin, Scott J.
Jani, Chinmay
Rupal, Arashdeep
Singh, Harpreet
Bourque, Daniel
Colgrove, Robert C.
Abstract:: Abstract : Supplemental Digital Content is Available in the Text.
Is Part Of:: American journal of therapeutics. Volume 28:Number 5(2021)
Journal:: American journal of therapeutics
Issue:: Volume 28:Number 5(2021)
Issue Display:: Volume 28, Issue 5 (2021)
Year:: 2021
Volume:: 28
Issue:: 5
Issue Sort Value:: 2021-0028-0005-0000
Page Start:
Page End:
Publication Date:: 2021-09
Subjects:: Chemotherapy -- Periodicals
Pharmacology -- Periodicals
615.58
Journal URLs:: http://journals.lww.com/americantherapeutics/pages/default.aspx ↗
http://journals.lww.com ↗
DOI:: 10.1097/MJT.0000000000001412 ↗
Languages:: English
ISSNs:: 1075-2765
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0838.780000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19840.xml